Skip to Content

Amcad Biomed Corp 4188

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4188 is trading at a 44% discount.
Price
TWD 26.74
Fair Value
TWD 85.86
Uncertainty
Extreme
1-Star Price
TWD 522.57
5-Star Price
TWD 1.19
Economic Moat
Bsj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4188 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
22.07
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from Europe. The company has two segments: Medical diagnostic software: which is responsible for the development and sales of smart medical imaging diagnostic software device and Precision medical equipment: which is responsible for research, development, manufacturing and sales of high-end ultrasonic probes.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
34

Valuation

Metric
4188
Price/Earnings (Normalized)
Price/Book Value
3.76
Price/Sales
22.07
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
4188
Quick Ratio
12.23
Current Ratio
13.35
Interest Coverage
−384.79
Quick Ratio
4188

Profitability

Metric
4188
Return on Assets (Normalized)
−7.98%
Return on Equity (Normalized)
−10.49%
Return on Invested Capital (Normalized)
−9.12%
Return on Assets
4188
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHhcynrlYwrcp$184.2 Bil
SYK
Stryker CorpCpqkdvlgyvPdkh$125.1 Bil
MDT
Medtronic PLCTvdmslnDkkxjl$108.5 Bil
BSX
Boston Scientific CorpLsxprvlwlHvxjj$107.1 Bil
EW
Edwards Lifesciences CorpGxcbbyttcGchltmt$51.4 Bil
DXCM
DexCom IncSgdfflkmxrPcjp$50.8 Bil
ZBH
Zimmer Biomet Holdings IncQfpxwcbsfzRlxy$25.0 Bil
PHG
Koninklijke Philips NV ADRTqncmxgxLkfpsk$24.4 Bil
ALGN
Align Technology IncQpnbkbdzSldfyps$21.7 Bil
PODD
Insulet CorpNyvcppphxMdpdfs$12.2 Bil

Sponsor Center